Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biophytis SA - American Depositary Share
(NQ:
BPTS
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biophytis SA - American Depositary Share
< Previous
1
2
3
Next >
Biophytis is Deploying its Partnership Strategy in Obesity
April 29, 2024
Via
ACCESSWIRE
Biophytis Announces Transfer of ADSs to OTC Market
April 24, 2024
Via
ACCESSWIRE
Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program
April 18, 2024
Via
ACCESSWIRE
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
April 17, 2024
Via
ACCESSWIRE
Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities
April 08, 2024
Via
ACCESSWIRE
Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)
April 08, 2024
Via
ACCESSWIRE
Results of the Combined General Meeting on April 2, 2024
April 04, 2024
Via
ACCESSWIRE
Biophytis: Results of the Annual General Meeting on June 16, 2023 All Resolutions Presented by the Company Have Been Adopted
June 16, 2023
Via
ACCESSWIRE
Biophytis Announces Receipt of Nasdaq Notice
November 17, 2023
Via
ACCESSWIRE
Biophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in Brazil
October 30, 2023
Via
ACCESSWIRE
Biophytis Receives Notice of Delisting From Nasdaq and Announces It Will Request a Hearing Before the Nasdaq Hearings Panel
October 27, 2023
Via
ACCESSWIRE
Biophytis Releases Its Half-Yearly Accounts as of 30 June 2023 and Provides an Update on Its Operations
September 27, 2023
Via
ACCESSWIRE
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise
September 26, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END
Via
FinancialNewsMedia
Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)
September 25, 2023
Via
ACCESSWIRE
Biophytis Provides an Update on its Early Access Programs for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19
September 19, 2023
Via
ACCESSWIRE
Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
September 14, 2023
Via
ACCESSWIRE
Biophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in Sarcopenia
September 11, 2023
Via
ACCESSWIRE
Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York
September 04, 2023
Via
ACCESSWIRE
Biophytis Announces Next Regulatory Steps in Europe and the United States for its COVA Project
August 16, 2023
Via
ACCESSWIRE
Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe
August 08, 2023
Via
ACCESSWIRE
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19
July 20, 2023
Via
ACCESSWIRE
Biophytis Announces $3.8 Million Registered Direct Offering
July 19, 2023
Via
ACCESSWIRE
Russell 2000 ETF Momentum Sparks Volatility In Small Caps
July 18, 2023
The iShares Russell 2000 ETF (NYSE: IWM) impressive upward momentum has led to a volume, attention, and volatility surge in the small-cap market.
Via
MarketBeat
Topics
ETFs
Initial Public Offering
Biophytis and SEQENS Sign a Partnership to Produce Sarconeos (BIO101) Active Compound
July 18, 2023
Via
ACCESSWIRE
Biophytis Has Filed with The FDA For Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia
July 10, 2023
Via
ACCESSWIRE
Biophytis Reports Clinical Results for Sarconeos (BIO101) in Sarcopenia Treatment at the 16th SCWD International Congress
June 19, 2023
Via
ACCESSWIRE
Biophytis to Participate at the BIO International Convention in Boston from the 5th to the 8th of June
June 05, 2023
Via
ACCESSWIRE
Biophytis has Filed with the French National Authority for Health (HAS) an Application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19
May 26, 2023
Via
ACCESSWIRE
Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
May 25, 2023
Via
ACCESSWIRE
Biophytis has Filed with the EMA for Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia
May 15, 2023
Via
ACCESSWIRE
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
